Fibrates are an important class of drugs for the management of dyslipidemia. This class of
drugs is generally well tolerated but is infrequently associated with several safety issues …

The biology of peroxisome proliferator activated receptors (PPARs) in physiological and
pathophysiological processes has been primarily studied in peripherial organs and tissues …

The peroxisome proliferator activated receptor gamma (PPARγ) is a member in the nuclear
receptor superfamily which mediates part of the regulatory effects of dietary fatty acids on …

Peroxisome proliferator-activated receptor (PPAR) α is a nuclear receptor activated by
natural ligands such as fatty acids as well as by synthetic ligands such as fibrates currently …

Both statins and peroxisome proliferator-activated receptor (PPAR) γ ligands have been
reported to protect against the progression of atherosclerosis. In the present study, we …

Atherosclerosis is a chronic inflammatory condition initiated in the endothelium in response
to injury and maintained through the interactions between modified lipoproteins …

Peroxisome proliferator‐activated receptors (PPARs) as ligand‐activated nuclear receptors
involved in the transcriptional regulation of lipid metabolism, energy balance, inflammation …

The discovery of the peroxisome proliferator-activated receptors (PPARs) in 1990s provided
new insights in understanding the mechanisms involved in the control of energy …

Fifteen weeks of dietary n-3 PUFA deprivation increases coefficients of conversion of
circulating α-linolenic acid (α-LNA; 18: 3n-3) to docosahexaenoic acid (DHA; 22: 6n-3) in rat …

Macrophages acquire their capacity for efficient phagocytosis of apoptotic cells during their
differentiation from monocytes. The peroxisome proliferator‐activated receptor gamma …